Theriva Biologics, Inc.
AMEX: TOVX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange American
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Steven A. Shallcross
- Employees
- 20
- Headquarters
- Rockville, United States
- IPO year
- 2006
- Market cap
- $9.0M
- Website
- https://therivabio.com
Loading TOVX…
Loading profile data…Frequently asked questions about TOVX
What does Theriva Biologics, Inc. (TOVX) do?
Theriva Biologics Inc. is a clinical-stage biotechnology firm dedicated to developing novel treatments for conditions with significant unmet medical needs. The company's pipeline features several promising candidates, including SYN-004, which is engineered to break down commonly used intravenous beta-lactam antibiotics in the gastrointestinal tr...
Where does TOVX trade?
Theriva Biologics, Inc. (TOVX) trades on the New York Stock Exchange American.
What sector is TOVX in?
Theriva Biologics, Inc. (TOVX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Theriva Biologics, Inc.?
Steven A. Shallcross is the chief executive officer of Theriva Biologics, Inc. (TOVX).
Where is Theriva Biologics, Inc. headquartered?
Theriva Biologics, Inc. is headquartered in United States.
Does TOVX pay a dividend?
Theriva Biologics, Inc. (TOVX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TOVX go public?
Theriva Biologics, Inc. (TOVX) completed its initial public offering in 2006.